Zhou Yang1,2
Ping Liu
Weijian Zhu- 1Department of Orthopedics, Lichuan Hchorizon Hexie Hospital, Lichuan, China
- 2Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 3Department of Respiration, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 4Department of Oncology, Zhongshan Hospital of Dalian University, Dalian, China
- 5Department of Orthopedics, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Background: Aspergillus fumigatus spondylitis is a rare fungal spondylitis that often occurs in immunocompromised patients. This article reports a case of Aspergillus spondylitis with specific image signs, which is rarely reported in an immunocompetent patient.
Case presentation: This is a case of L3-4 segmental Aspergillus spondylitis diagnosed. The diagnosis was confirmed by intraoperative metagenomic next-generation sequencing (mNGS) testing of the diseased tissue. The patient was treated with voriconazole and underwent surgical debridement and internal fixation with pedicle screws.
Conclusion: The diagnosis of Aspergillus spondylitis is often delayed or missed. Doctors should consider Aspergillus spondylitis in the differential diagnosis of unexplained low back pain so that appropriate treatment can be administered to prevent spinal cord injury and disability. Aspergillus spondylitis usually results in endplate inflammatory response line on fluid or enhancement sequences and a diffuse low signal in the diseased vertebral body on T2-weighted imaging (T2WI). It also results in large paraspinal abscesses, which requires further research to better differentiate between Aspergillus spondylitis and tuberculous spondylitis. Prompt diagnosis and treatment can improve the patient’s prognosis.
1 Introduction
Aspergillus fumigatus spondylitis is exceptionally rare, particularly in immunocompetent individuals without typical risk factors for fungal infections (1). This case highlights the need to consider Aspergillus as a potential cause in cases of refractory infections and underscores the critical role of surgical intervention in managing such conditions. Imaging features often include endplate inflammatory response line on fluid-sensitive or contrast-enhanced sequences, diffuse hypointensity in the affected vertebrae on T2WI, and the presence of large paraspinal abscesses, which may serve as distinguishing characteristics of Aspergillus spondylitis.
A literature review was conducted via PubMed using the keywords Aspergillus, aspergillosis, Aspergillus fumigatus, vertebral osteomyelitis, and spondylodiscitis (Table 1). Patients with multiple causes of immunodeficiency were excluded, including those with HIV infection, hematologic malignancies, chronic liver or kidney disease, solid organ transplantation, immunosuppressive chemotherapy, or corticosteroid treatment. Risk factors for Aspergillus infection, such as chronic obstructive pulmonary disease (COPD), tuberculosis, trauma- or surgery-associated infection, and intravenous drug use, were included.
Table 1. Clinical characteristics of Aspergillus spondylitis in immunocompetent patients.
A retrospective review identified 11 cases of Aspergillus spondylitis in immunocompetent patients over the past decade, including the present case. The mean age of the patients was 52 years, with a male predominance (82%). The most common clinical manifestations included back or neck pain, occasionally accompanied by fever or neurologic dysfunction. Lumbar spine involvement was the most frequent, accounting for 73% of the cases. The overall treatment outcomes were favorable, with 91% of patients achieving complete recovery. However, one case resulted in severe sequelae. Sixty percent of the cases were managed with a combination of antifungal therapy and surgical intervention, with treatment durations ranging from 4 weeks to 12 months (1–10).
2 Case report
A 27-year-old man presented with low back pain for over a month, which worsened with activity. He had no fever, night sweats, headache, or chest or abdominal pain. His medical history was notable for the absence of immunocompromise and a family history of genetic disorders. T2WI revealed diffuse hypodensity of the L3-4 vertebral body with inflammatory disk erosion, although the disk height remained unchanged. Enhancement sequences demonstrated diffuse hyperdense signals in the L3-4 vertebral body with endplate inflammatory reaction lines (Figure 1).
Figure 1. Figure (A) shows the enhancement sequence, with the endplate inflammatory reaction line indicated by the white arrow. Figures (B,C) display axial and coronal enhancement, respectively, highlighting inflammatory involvement of the surrounding soft tissues. Figure (D) shows the T2WI sequence, with density 1 measuring 147 and density 2 measuring 90.
Physical examination revealed limited lumbar spine motion, positive tenderness over the L3-4 spinous process and paravertebral area, and no neurologic deficits. Laboratory tests showed a white blood cell (WBC) count of 7.09 × 109/L, a neutrophil percentage of 64.9%, a C-reactive protein (CRP) level of 53.1 mg/L, and an erythrocyte sedimentation rate (ESR) of 45 mm/h. All other microbiologic tests were negative.
To alleviate the patient’s pain and reduce inflammation, cefoperazone was administered intravenously at a dose of 7.5 g on the second day after admission. This was subsequently adjusted to 2.5 g intravenously twice daily for 5 days. However, five days later, the patient reported increased low back pain and fever, with a temperature rising to 38.5°C. With the patient’s consent, a posterior lumbar lesion debridement, autologous iliac bone grafting, and pedicle screw fixation were performed to stabilize the spine and remove the lesion (Figure 2).
Figure 2. Figures (A,B) display the postoperative frontal and lateral plain radiographs, respectively. Figure (C) illustrates the histopathological findings of the postoperative vertebral body and disk. The affected intervertebral disk and adjacent vertebral body tissue were predominantly composed of fibrous connective tissue, with localized areas of hemorrhage, necrosis, and scattered neutrophilic infiltration. The magnification of the upper image is 10×, while that of the lower image is 4×.
Postoperative mNGS confirmed Aspergillus infection (Supplementary Table 1), whereas Mycobacterium tuberculosis culture results and general bacterial cultures were negative. The treatment regimen was adjusted to intravenous voriconazole, initially at a dose of 300 mg, followed by 300 mg twice daily. After 2 days, the regimen was changed to oral voriconazole at 400 mg twice daily. The patient continued antifungal therapy at home for 1 month. During this period, we conducted blood concentration monitoring of voriconazole in the patient, and the result showed that the blood concentration was maintained at around 2 mg/L.
The patient was followed up for a period of 1 year. At the one month follow-up after the procedure, the symptoms had resolved. Laboratory tests reviewed at this time showed a WBC count of 6.81 × 109/L, a neutrophil percentage of 59.4%, a CRP level of 1.6 mg/L, and an ESR of 6 mm/h. and no recurrence of disease was noted by the end of the 1-year follow-up.
3 mNGS detection procedures
In our study, samples were collected following standardized clinical procedures to ensure representativeness and integrity. For instance, fresh infected tissue samples were obtained under sterile conditions in the operating room to minimize contamination. After collection, samples were promptly processed for nucleic acid extraction. Commercial kits were used for nucleic acid extraction, and all steps were performed in accordance with the manufacturer’s instructions to ensure high-quality nucleic acid extraction.
Sequencing libraries were constructed from the extracted nucleic acids through fragmentation, end-repair, and adapter ligation. We used the Illumina NovaSeq platform for high-throughput sequencing. During sequencing, real-time quality control was implemented to monitor data accuracy and reliability. Low-quality sequencing data were filtered out using established bioinformatics tools.
Quality control is a critical component of our mNGS workflow. For sample quality, we ensured that all samples were collected and handled under optimal conditions to prevent degradation and contamination. The purity of nucleic acids was assessed using a NanoDrop spectrophotometer, with acceptable A260/A280 ratios. Library quality was evaluated by agarose gel electrophoresis and Qubit fluorometry to ensure proper concentration and fragment size distribution. For sequencing data quality, we utilized FastQC to assess key metrics such as base quality, sequencing depth, and GC content. Any low-quality reads were removed to ensure high-quality data for downstream analysis.
Our bioinformatics pipeline is designed to provide accurate and comprehensive results. After data preprocessing with Trimmomatic to remove adapter sequences and low-quality bases, the cleaned reads were aligned to reference databases using tools like Bowtie2 and BLAST. This alignment process allows us to identify the presence of various microorganisms, including bacteria, viruses, and fungi. We further analyzed the abundance of each detected microorganism to assess the potential severity of infection.
We established clear criteria for interpreting positive results based on the sample type and clinical context. We set appropriate positivity thresholds accordingly. Moreover, we carefully considered the clinical relevance of positive results by integrating patients’ clinical symptoms, medical history, and laboratory test results. To rule out contamination, especially for low-abundance positives, we traced back every step from sample collection to sequencing.
In the case of our patient, the mNGS detection identified Aspergillus fumigatus with a sequence count of 10. This result was interpreted in the context of the patient’s clinical presentation and history. The detection of Aspergillus fumigatus that was considered significant given the patient’s clinical symptoms and the potential for invasive fungal infections. The positivity threshold and clinical relevance were carefully evaluated, and the result was communicated to the clinical team to assist in guiding appropriate antifungal therapy.
4 Discussion
Aspergillus spondylitis is a rare but potentially devastating condition that can occur in both immunocompromised and immunocompetent individuals (11). In this case report, we describe a patient with Aspergillus spondylitis diagnosed through mNGS, highlighting the importance of advanced diagnostic techniques in the management of such infections.
mNGS has emerged as a powerful tool for identifying pathogens in complex infections, including spinal infections (12, 13). It allows for the detection of a broad range of microbial pathogens directly from clinical samples, without the need for prior culture or specific amplification. This technique is particularly useful in cases where traditional culture methods have low sensitivity or when the pathogen is difficult to cultivate (14). In our case, mNGS was able to identify Aspergillus species in the patient’s tissue samples, despite previous negative results from conventional cultures. This finding underscores the importance of considering mNGS as a diagnostic tool, especially in cases where traditional methods are inconclusive.
The diagnosis of Aspergillus spondylitis can be particularly challenging due to its nonspecific clinical and radiological presentations. Patients often present with back pain, fever, and neurological deficits, which can mimic other more common spinal infections such as tuberculosis or pyogenic spondylitis (15). Traditional diagnostic methods, including blood cultures and histopathological examination, may not always yield definitive results, especially in the early stages of the disease (4). In our case, the initial diagnosis was inconclusive, and it was only through mNGS that the presence of Aspergillus was confirmed. This highlights the crucial role of mNGS in identifying the causative pathogen, especially when conventional methods fail.
Clinically, our patient presented with progressive back pain and neurological deficits, which are common symptoms in Aspergillus spondylitis (3, 10, 15). Imaging studies revealed vertebral destruction and paravertebral inflammatory mass, findings that are consistent with previous reports (5, 10, 11). Interestingly, the enhanced imaging sequence in this case revealed endplate inflammatory reaction lines, findings that align with recent reports by Xu et al. (9) and Jin and Yin (10). Furthermore, T2WI revealed diffuse low signal intensity of the vertebral body (Figure 1), which Xu et al. (9) suggest may result from the paramagnetic material produced by Aspergillus. Therefore, large-scale research and investigation are still required to elucidate the specific imaging features of Aspergillus spondylitis.
The management of Aspergillus spondylitis typically involves a combination of antifungal therapy and surgical intervention. In our case, the patient was treated with voriconazole, which is recommended as the first-line antifungal agent for Aspergillus infections (16, 17). Voriconazole has demonstrated efficacy in treating invasive aspergillosis, with a favorable safety profile and good bone penetration (17). Long-term voriconazole therapy can lead to adverse effects such as visual disturbances, hepatotoxicity, and photosensitivity (18). Regular monitoring of liver function, visual assessments, and avoiding excessive sun exposure are essential for managing these risks (18, 19). Additionally, voriconazole has a complex interaction profile, and careful review of concomitant medications is necessary to avoid adverse effects (18, 20). Surgical intervention, including debridement and spinal stabilization, is often necessary to address complications such as spinal instability and neurological compression (1, 6, 7). Our patient underwent surgical debridement and stabilization, which significantly improved their clinical outcome.
Early fungal spondylitis diagnosis and treatment are critical in preventing severe complications such as spinal deformity and permanent neurological damage (Table 2). Delayed diagnosis can lead to the progression of the disease, necessitating more extensive surgical interventions and prolonged antifungal therapy (6, 10). In our case, the use of mNGS facilitated early identification of the pathogen, allowing for prompt initiation of appropriate treatment.
Table 2. MRI differences between pyogenic spondylitis, tuberculous spondylitis and fungal spondylitis.
5 Conclusion
Aspergillus spondylitis is a rare but serious condition that requires a high index of suspicion and advanced diagnostic techniques for early identification. mNGS has proven to be a valuable tool in confirming the diagnosis, especially when traditional methods are inconclusive. A combination of antifungal therapy and surgical intervention is often necessary to achieve optimal outcomes. However, this case report has several limitations. First, it is a single case report, which limits the generalizability of the findings. Second, the long-term outcomes and the impact of voriconazole therapy on patient quality of life require further evaluation. Third, the specific imaging features of Aspergillus spondylitis need to be validated in larger cohorts. Future studies should focus on multi-center collaborations to increase sample size, conduct long-term follow-up to assess treatment outcomes, and explore advanced imaging techniques to better differentiate Aspergillus spondylitis from other spinal infections.
Data availability statement
The original contributions presented in this study are included in this article/Supplementary material, further inquiries can be directed to the corresponding authors. Gene sequencing has been uploaded into the NCBI database (http://www.ncbi.nlm.nih.gov/bioproject/1202223).
Ethics statement
The studies involving humans were approved by the Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
ZhouY: Validation, Writing – original draft. SZ: Data curation, Investigation, Methodology, Software, Writing – review and editing. ZhiY: Writing – review and editing. PL: Writing – review and editing. SC: Data curation, Methodology, Resources, Writing – review and editing. WZ: Writing – original draft.
Funding
The authors declare that no financial support was received for the research and/or publication of this article.
Acknowledgments
This is a short text to acknowledge the contributions of specific colleagues, institutions, or agencies that aided the efforts of the authors.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The authors declare that no Generative AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmed.2025.1575363/full#supplementary-material
Abbreviations
mNGS, metagenomic next-generation sequencing; T2WI, T2-weighted imaging; COPD, chronic obstructive pulmonary disease; WBC, white blood cell; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate.
References
1. Lyons M, Neal M, Patel N, Vikram H. Progressive back pain due to aspergillus nidulans vertebral osteomyelitis in an immunocompetent patient: Surgical and antifungal management. Case Rep Orthopedics. (2019) 2019:4268468. doi: 10.1155/2019/4268468
2. Aydın Ö, Bektaş B, Aslan A, Yıldırım AN, Arslan F. Voriconazole-treated aspergillus vertebral osteomyelitis in an immunocompetent patient. J. Orthopaedic Sci. (2023) 28:710–2. doi: 10.1016/j.jos.2020.09.003
3. Comacle P, Le Govic Y, Hoche-Delchet C, Sandrini J, Aguilar C, Bouyer B, et al. Spondylodiscitis due to aspergillus terreus in an immunocompetent host: Case report and literature review. Mycopathologia. (2016) 181:575–81. doi: 10.1007/s11046-016-0007-6
4. Li Y, Cen Y, Luo Y, Zhu Z, Min S, Chen X. Aspergillus vertebral osteomyelitis complicating pulmonary granuloma in an immunocompetent adult. Med. Principles Pract. (2016) 25:394–6. doi: 10.1159/000443310
5. Rashid M, Hossain M, Ahmed N, Kazi R, Ferini G, Palmisciano P, et al. Aspergillus spinal epidural abscess: A case report and review of the literature. J. Craniovertebral Junct. Spine (2022) 13:204–11. doi: 10.4103/jcvjs.jcvjs_35_22
6. Reed T, Shtaya A, Beard K, Saeed K, Glover S, Fabian M, et al. Aspergillus fumigatus causing vertebral osteomyelitis in an immunocompetent patient: A case report and literature review. Le Infezioni Med. (2022) 31:108–12. doi: 10.53854/liim-3101-15
7. Takagi Y, Yamada H, Ebara H, Hayashi H, Kidani S, Okamoto S, et al. Aspergillus terreus spondylodiscitis following an abdominal stab wound: A case report. J. Med. Case Rep. (2019) 13:172. doi: 10.1186/s13256-019-2109-5
8. Yoon K, Kim Y. Lumbar aspergillus osteomyelitis mimicking pyogenic osteomyelitis in an immunocompetent adult. Br. J. Neurosurg. (2015) 29:277–9. doi: 10.3109/02688697.2014.957648
9. Xu Z, Zhu W, Zhou S, Zhao Y, Xiang Q, Zhang Y. Aspergillus fumigatus spondylitis in an Immunocompetent patient with annular high signal around the intervertebral disks: A case report and literature review. Front. Med. (2024) 11:1532282. doi: 10.3389/fmed.2024.1532282
10. Jin Y, Yin X. Aspergillus terreus spondylodiscitis following acupuncture and acupotomy in an immunocompetent host: Case report and literature review. Front. Cell. Infect. Microbiol. (2023) 13:1269352. doi: 10.3389/fcimb.2023.1269352
11. Dong S, Lin Q, Dai X, Lin Z. An immunocompetent host with blood-disseminated aspergillus versicolor spondylitis: A case report and literature review. J. Int. Med. Res. (2024) 52:3000605241234574. doi: 10.1177/03000605241234574
12. Tang Y, Zhao D, Wang S, Yi Q, Xia Y, Geng B. Diagnostic value of next-generation sequencing in periprosthetic joint infection: A systematic review. Orthopaedic Surg. (2022) 14:190–8. doi: 10.1111/os.13191
13. Fang X, Cai Y, Chen X, Huang C, Lin Y, Huang Z, et al. The role of metagenomic next-generation sequencing in the pathogen detection of invasive osteoarticular infection. Int. J. Infect. Dis. (2022) 122:996–1001. doi: 10.1016/j.ijid.2022.07.061
14. Zhang C, Fang X, Huang Z, Bai G, Zhang Z, Yang Y, et al. Surgical management for chronic destructive septic hip arthritis: Debridement, antibiotics, and single-stage replacement is as effective as two-stage arthroplasty. Orthopaedic Surg. (2022) 14:1175–85. doi: 10.1111/os.13301
15. Zhu W, Zhou S, Zhang J, Li L, Liu P, Xiong W. Differentiation of native vertebral osteomyelitis: A comprehensive review of imaging techniques and future applications. Med. Sci. Monit. (2024) 30:e943168. doi: 10.12659/msm.943168
16. Herbrecht R, Patterson T, Slavin M, Marchetti O, Maertens J, Johnson E, et al. Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin b for therapy of invasive aspergillosis: A collaborative study of the mycoses study group (Msg 05) and the European organization for research and treatment of cancer infectious diseases group. Clin. Infect. Dis. (2015) 60:713–20. doi: 10.1093/cid/ciu911
17. Herbrecht R, Denning D, Patterson T, Bennett J, Greene R, Oestmann J, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N. Engl. J Med. (2002) 347:408–15. doi: 10.1056/NEJMoa020191
18. Hamada Y, Tokimatsu I, Mikamo H, Kimura M, Seki M, Takakura S, et al. Practice guidelines for therapeutic drug monitoring of voriconazole: A consensus review of the japanese society of chemotherapy and the japanese society of therapeutic drug monitoring. J. Infect. Chemother. (2013) 19:381–92. doi: 10.1007/s10156-013-0607-8
19. Hussaini T, Rüping M, Farowski F, Vehreschild J, Cornely O. Therapeutic drug monitoring of voriconazole and posaconazole. Pharmacotherapy (2011) 31:214–25. doi: 10.1592/phco.31.2.214
Keywords: Aspergillus fumigatus, Aspergillus, infectious spondylitis, immunocompetent, clinical features
Citation: Yang Z, Zhou S, Yang Z, Liu P, Chen S and Zhu W (2025) Metagenomic next-generation sequencing enabled diagnosis of Aspergillus spondylitis in an immunocompetent patient: a case report and literature review. Front. Med. 12:1575363. doi: 10.3389/fmed.2025.1575363
Received: 12 February 2025; Accepted: 09 April 2025;
Published: 30 April 2025.
Edited by:
Sam Donta, Falmouth Hospital, United StatesReviewed by:
Soo-youn Moon, Kyung Hee University Hospital at Gangdong, Republic of KoreaJiangqin Song, Tianmen First People’s Hospital, China
Copyright © 2025 Yang, Zhou, Yang, Liu, Chen and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shanming Chen, Y2hlbnNoYW5taW5nQHNvaHUuY29t; Weijian Zhu, MTU5NTYwNjUwNDFAMTYzLmNvbQ==